Cancer in Tasmania Incidence and Mortality 2012 Tasmanian Cancer Registry University of Tasmania Menzies Research Institute Tasmania 17 Liverpool Street Hobart Tasmania Australia 7000 Postal address: Private Bag 23 Hobart Tasmania Australia 7000 Telephone (03) 6226 7757 Facsimile (03) 6226 7755 URL: www.menzies.utas.edu.au/cancer_reg.html Email: tcr@menzies.utas.edu.au Editors: Stokes B, Albion T, Otahal P, Venn A. Publication date: May 2015
Acknowledgements The Tasmanian Cancer Registry is funded by the Tasmanian Department of Health and Human Services (DHHS), through its Population Health subdivision, and by the Menzies Research Institute Tasmania. Additional funds are raised from the community and research funding bodies. The work of collecting and collating cancer registry data would not be possible without the continuing assistance and support of a number of people. These include staff members of: Private and public pathology laboratories Private radiology laboratories The Registry of Births, and Marriages Medical Records Departments of all Tasmanian hospitals WP Holman Clinics Launceston and Hobart Medical practitioners in specialist and general practices The Australian Bureau of Statistics Other State and Territory cancer registries The assistance provided by the Registry s Advisory Committee is greatly appreciated. The administrative staff and volunteers of the Registry are commended for their commitment and efforts towards achieving the high level of accuracy and completeness of data upon which this report is based. We also thank other Menzies Research Institute Tasmania staff for their assistance with statistical, computing, administrative, financial, media and editorial matters. Citation The following citation is suggested in referring to this report: Stokes B, Albion T, Otahal P, Venn A. Cancer in Tasmania: Incidence and Mortality 2012. Menzies Research Institute Tasmania, Hobart, May 2015. 2 Tasmanian Cancer Registry
Tasmanian Cancer Registry Staff Prof A Venn Mr B Stokes Mrs K Jackman Mrs R Wilson Mrs N Wiggins Assoc Prof L Blizzard Mr T Albion Mr P Otahal Director Manager Administrative Officer Administrative Officer Project Officer Biostatistician, Menzies Research Institute Tasmania Senior Database Administrator / IT Systems Designer, Menzies Research Institute Tasmania Biostatistician, Menzies Research Institute Tasmania Members of the Advisory Committee 2013-14 Ms P Egan Dr K Shaw Ms G Sidhu Dr P Stanton Ms G Ward The Cancer Council Tasmania Department of Health and Human Services, Tasmania Australian Bureau of Statistics, Tasmania General Surgeon Department of Health and Human Services, Tasmania Tasmanian Cancer Registry 3
4 Tasmanian Cancer Registry
Contents The Tasmanian Cancer Registry... 7 Introduction... 7 Sources of data... 7 Data handling, collection and coding practices... 7 Data control and quality assurance... 8 Publication of reports... 8 Uses of data... 8 Changes in registration & reporting... 9 All Cancers... 10 Incidence and mortality of all cancers 2012... 10 Trends for all cancers 1980 2012... 11 Common Cancers... 12 Common cancers diagnosed in males 2012... 12 Common cancer-related deaths in males 2012... 12 Common cancers diagnosed in females 2012... 13 Common cancer-related deaths in females 2012... 13 Female breast cancer 1997-2012... 14 Tumour size... 14 Lymph node involvement... 14 Regional Distribution of Cancers... 15 Common Cancers by Local Government Area... 16 Common Cancers Diagnosed in Males between 2008-2012... 16 Common Cancers Diagnosed in Females between 2008-2012... 18 Common Cancers Diagnosed in All Persons between 2008-2012... 20 Cancer incidence and mortality table 2012... 23 Differences in reporting due to coding changes... 61 Appendices... 63 Appendix A: Cancer site codes and combinations... 64 Appendix B: Statistical methods... 66 Appendix C: Population data... 67 Appendix D: Indices of data quality... 68 Appendix E: Use of Tasmanian Cancer Registry Data... 70 Appendix F: Incidence and mortality summary tables 2012... 72 References... 74 Tasmanian Cancer Registry 5
6 Tasmanian Cancer Registry
The Tasmanian Cancer Registry Introduction The Tasmanian Cancer Registry was established in 1977 as a population-based registry covering the whole of Tasmania. The Registry provides the State Government with accurate cancer incidence and mortality statistics and monitors cancer trends. In July 1988 the operation of the Cancer Registry was moved from the Department of Health Services to the Menzies Research Institute Tasmania. Cancer was declared a notifiable disease in December 1992 and cancer registration since then has had a legislative basis. Registry staff include a Director, Manager and 2 Administrative Officers. Volunteers also assist on occasion with administrative functions. The Registry has access to a biostatistician and a computer consultant. An Advisory Committee assists the Registry. The Tasmanian Cancer Registry is a full member of the Australasian Association of Cancer Registries (AACR) and the International Association of Cancer Registries (IACR). Sources of data All pathology laboratories in the State provide the Registry with copies of histopathological and cytology reports of cancer and cell marker reports. Cancer notification forms are supplied by the two radiation oncology clinics. Private and public hospitals notify diagnoses of cancer to the Registry upon discharge of patients or provide a computerised listing of cancer cases periodically. Death notifications of Tasmanian people are reviewed for mention of cancer as a cause of death. Since 1994 breast and cervical cancer screening programs have been undertaken in Tasmania and listings from these sources are available to check against Registry records. Interstate registries supply data to the Tasmanian Cancer Registry on Tasmanian residents who seek treatment interstate or who move interstate at some time after cancer diagnosis. Data handling, collection and coding practices Paper copies of all scanned notifications are retained until coding and validation of cases for that year is complete. Data for cancers diagnosed between 1 January 2012 and 31 December 2012 were registered on an MS SQL (with ACCESS front-end) database developed in house for the Tasmanian Cancer Registry. This database was developed to enable: the registration of cancers using International Classification of Diseases for Oncology, Third Edition (ICD-O3) 1 codes; the electronic transfer and processing of cancer incidence and death notifications; the collection of the minimum dataset defined by the Australasian Association of Cancer Registries members; and improved access and manipulation of registry data for data requests and reporting. Information collected by the Registry includes demographic and clinical data for the patient with cancer in accordance with the minimum data defined in the Cancer Registries Data Dictionary. Additional tumour data are collected for melanomas, lymphomas, unknown primaries, and breast and bladder cancers. The Tasmanian Cancer Registry collects and registers nonmelanoma skin cancers (NMSC) on a register established in 2001 for this purpose. Currently NMSC registrations are complete from 1978 to 2005. NMSC notifications are registered only when additional funding sources are obtained. Resource considerations prevent the routine registration of these cancers and the pathology reports are stored until additional funds become available. Both the primary site and morphology of cancers diagnosed in Tasmania in 2012 were coded to the International Classification of Diseases for Oncology, Third Edition (ICD- O3). This report presents data for invasive cancers only (behaviour = 3, site C000 C809). In situ cancers and second primary cancers with the same three-digit topography code and related morphologies are not included in this report. Coding practices specific to the Tasmanian Cancer Registry are detailed in Appendix A on page 64. In this report, incidence refers to the number of new primary tumours that are diagnosed in the Tasmanian population in any year, rather than the number of people with cancer. While the Tasmanian Cancer Registry registers multiple primary cancers diagnosed in a person, not all primary tumours are reported in incidence rates according to the rules for incidence reporting recommended by the International Agency for Research on Cancer. Applying these rules to incidence reporting improves Tasmanian Cancer Registry 7
the comparability of Tasmanian cancer data with national and international cancer data. Data control and quality assurance The quality of information provided by the Registry depends on the quality of data received. The indices used to measure the quality of the 2012 data are provided in Appendix D on page 68. To help achieve high data quality and case ascertainment, data are obtained from multiple sources such as pathology laboratories, hospitals and the Registrar of Births, and Marriages. Most registered cases include data from both a pathology laboratory and a hospital service (inpatient or radiation oncology clinic). Where insufficient information is received to enable complete registration, active follow-up is undertaken by contacting treating doctors, pathology laboratories and hospital medical record departments. Monitor the number of new cases of cancer in Tasmania Compare local and national cancer trends Plan services for cancer control and the care of people with cancer in Tasmania Assist in gathering information about cancer treatment, cancer care and cancer programs Provide information for research into the causes of cancer and the results of prevention, screening and treatment services Contribute to Australia-wide reporting on the number of people with cancer and their eventual outcomes. The quality also depends on the accuracy of data processing by the Registry. The Registry s information system is able to detect a number of errors when data entry is performed. Data matching programs enable the identification and amendment of duplicate entries by identifying incorrect spellings, name changes and date of birth inconsistencies. In addition, the National Cancer Statistics Clearing House (NCSCH) collates all state and territory data and checks for duplicate registrations across two or more states. On average, the Registry receives cancer notifications once or twice a week from pathology laboratories, half yearly and adhoc from hospitals, and monthly from the Registrar of Births, and Marriages. The cases are usually registered within twelve months of notification and resolution of incomplete information can take up to 24 months. Publication of reports The incidence and mortality data in this report are based on cancer registrations for 2012 and for 1980-2012 for trend analysis. Despite intensive efforts to ensure the completeness of incidence data, the database is continually updated with previously unregistered cases and new information for registered cases. The data in this report were complete as of 30 th April 2015. This improves the quality of data but future publications and responses to requests for data will reflect any subsequent revisions to the data and may not exactly correspond to the figures in this report. Uses of data The information collected by the Registry is used to: 8 Tasmanian Cancer Registry
Changes in registration & reporting This report provides a summary of cancer incidence and mortality statistics for Tasmania in 2012. It includes all cancers notified to the Tasmanian Cancer Registry that were first diagnosed in Tasmanian residents between 1 January 2012 and 31 December 2012. In this report, the primary site and morphology for cancers diagnosed in Tasmania in 2 were coded using the International Classification of Diseases for Oncology, Third Edition (ICD-O3) 1. In reports prior to 2003, the primary sites of cancers diagnosed in Tasmania were coded using the International Classification of Diseases for Oncology, Ninth Edition (ICD-9) and the morphologies were coded using the Systematized Nomenclature of Medicine and Modifications (SNOMED) and the International Classification of Diseases for Oncology, Second Edition (ICD-O2) 2. The Cancer in Tasmania 2003 report was the first to be produced using codes from ICD-03. In this report, cancers have been tabulated according to ICD- 10 3 codes (refer to Appendix A on page 62), but coded using ICD-O3. This allows comparisons to be made with national cancer incidence and mortality. Cancers were also tabulated in ICD-10 in the 2001 and 2002 annual reports, but were coded using ICD-9 and SNOMED/ICD-O2 codes. In earlier annual reports, cancers were tabulated in ICD-9, and coded using ICD-9 and SNOMED/ICD-O2 codes. Cancer types and groups are mostly comparable across reports. An explanation of differences in the reporting of cancers due to coding changes over the last few years is provided on page 61. A feature first introduced in the 2006 report shows rates for the four most common cancers for males, females and all persons, by Local Government Areas (LGAs) of residence. Reported rates are aggregated over 5 years (2008-2018). The incidence and mortality tables for 2012 report agestandardised rates using the World 2000 population in addition to the World 1960 and Australia 2001 populations. As in the 2011 report, summary information and figures in this report use age-standardised rates according to the Australian 2001 standard population instead of the World 1960 standard population. This change was made to be more consistent with national data published by the Australian Institute of Health and Welfare. In 2012, the Tasmanian Cancer Registry published a report entitled, Cancer Survival and Prevalence in Tasmania, 1978-2008. This report describes cancer survival and prevalence in Tasmanians diagnosed with cancer in 2004 to 2008 and is available online at http://www.menzies.utas.edu.au/pdf/tcrsurvivalreport.pdf In line with all other Australian state and territory cancer registries, the Tasmanian Cancer Registry routinely codes all melanomas of unknown site to ICD-03 C44 (skin), and these are reported as ICD-10 C43 Melanoma of Skin. This is consistent with reporting practices in the 2003-2011 reports. Melanoma morphology codes occurring at other sites are coded to the site in which they occurred. Cancers reported as C44 skin cancer include all malignant cancers of the skin, but exclude basal cell carcinoma, squamous cell carcinoma, melanoma (reported as ICD-10 C43), some Kaposi sarcomas (reported as ICD-10 C46), and some types of lymphomas (ICD-10 C81-C85). Tasmanian Cancer Registry 9
All Cancers Incidence and mortality of all cancers 2012 There were 3,160 new cases of cancer (excluding non-melanoma skin cancers) diagnosed among Tasmanian residents during 2012 (1,724 males and 1,436 females) representing a small increase over the previous year. The overall age standardised incidence was 552.4 per 100,000 for males and 434.4 per 100,000 for females a. The risk of developing any cancer by age 75 years was 1 in 3 for males and 1 in 4 for females, and by age 85 years was 1 in 2 for both males and females. The risk estimate does not include the risk of developing non-melanoma skin cancer. Cancer incidence generally increased with age (Figure 1). Male rates exceeded female rates for Tasmanians aged 50 years and over. Prostate and lung cancers were responsible for the greater male cancer incidence at these ages. Breast cancer accounted for the slightly higher female rates among younger adults. There were 1,216 (674 male and 542 female) cancer-related deaths among Tasmanian residents in 2012. The overall age standardised mortality rate was 221.5 per 100,000 for males and 151.8 per 100,000 for females. The person-years life lost to age 75 years was 4,093 for males and 3,420 for females. Figure 1: Age specific incidence and mortality for all cancers (excluding non-melanoma skin cancers) 2012 4000 3500 3000 Male Incidence Female Incidence Male Mortality Female Mortality Age-specific rates per 100,000 2500 2000 1500 1000 500 0 Age (years) a Age standardised incidence was calculated using the Australian 2001 Standard Population (reported in some previous annual reports using the World 1960 Standard Population). 10 Tasmanian Cancer Registry
Trends for all cancers 1980 2012 The age standardised incidence rates (ASR) of all cancers (excluding non-melanoma skin cancers) increased by 27.4% for males and 39.5% for females during the 32-year period from 1980 to 2012 (comparing 2011-2012 with 1980-1981), and decreased by 4.6% for males and increased by 0.6% for females during the period 2011 to 2012 (Figure 2). The cancers that had a particularly high incidence in 2012 compared to 1980 were prostate cancer and malignant melanoma in males, and malignant melanoma, breast cancer and lung cancer in females. In 2012 there was a small increase in the total number of newly diagnosed cancers, with age-standardised incidence rates for males slightly lower than in 2011, and females slightly higher for the same period (Figure 2). In males kidney, oesophagus and bladder cancers were somewhat higher than in 2011, while decreases were observed for prostate, rectum and all leukaemia cancers. In females, the incidence rates for breast, lung and kidney cancer increased whilst decreases were observed in melanoma of skin, colorectal and rectum cancers. While overall mortality rates remained similar to 2011 for both males and females (Figure 2), an increase was observed for all lymphomas in females and pancreatic cancer for males. Age standardised rates per 100,000 (Australia 2001) 750 700 650 600 550 500 450 400 350 300 250 200 150 100 Male Incidence Female Incidence Male Mortality Female Mortality Figure 2: Trends in age standardised incidence and mortality of all cancers (excluding non-melanoma skin cancers) 1980 2012* 50 0 Crude rates per 100,000 population 800 Male Incidence 750 Female Incidence 700 Male Mortality 650 Female Mortality 600 550 500 450 400 350 300 250 200 150 100 50 0 Year *Incidence and mortality for all cancers from 1980 to 2000 is reported in ICD-9 while data for 2001 to 2012 are reported in ICD-10. Figure 3: Trends in crude incidence and mortality of all cancers (excluding nonmelanoma skin cancers) 1980 2012* Year Tasmanian Cancer Registry 11
Common Cancers Common cancers diagnosed in males 2012 The most common cancer diagnosed in males in 2012 was prostate cancer, followed by colorectal cancer, lung cancer, melanoma of skin and all lymphomas. Figure 4: Common cancers diagnosed in males 2012 Prostate 446 Colorectal 241 Lung 181 Melanoma of skin 153 All lymphomas 74 0 100 200 300 400 500 Number of cancer cases Common cancer-related deaths in males 2012 The most common causes of cancer-related deaths in male Tasmanian residents in 2012 were lung cancer, colorectal cancer, prostate cancer, pancreatic and head and neck cancer. Figure 5: Common causes of cancer-related deaths in males 2012 Lung 144 Colorectal 88 Prostate 72 Pancreas 49 Head and neck 33 0 20 40 60 80 100 120 140 160 Number of cancer deaths 12 Tasmanian Cancer Registry
Common cancers diagnosed in females 2012 The most common cancer diagnosed in females in 2012 was breast cancer, followed by colorectal cancer, lung cancer, melanoma of skin and all lymphomas. Figure 6: Common cancers diagnosed in females 2012 Breast 394 Colorectal 208 Lung 141 Melanoma of skin 108 All lymphomas 61 0 100 200 300 400 500 Number of cancer cases Common cancer-related deaths in females 2012 The most common causes of cancer-related deaths in female Tasmanian residents in 2012 were lung cancer, breast cancer, colorectal cancer, pancreatic cancer and ovarian cancer. Figure 7: Common causes of cancer-related deaths in females 2012 Lung 95 Breast 69 Colorectal 57 Pancreas 30 Melanoma of skin 22 0 20 40 60 80 100 Number of cancer deaths Tasmanian Cancer Registry 13
Female breast cancer 1997-2012 The Tasmanian Cancer Registry first recorded breast cancer tumour size and lymph node involvement in 1997 when funding was provided to all Australian cancer registries for this purpose. Tumour size In 2012, 99% of the 394 primary breast cancer cases (female) were histologically examined a. Information about tumour size was available for 339 (87%) of these cases. Of these tumours, 72 (21%) were less than 10mm in diameter, 120 (35%) were between 10 and 19mm, 137 (40%) were between 20 and 49mm, and 10 (3%) were at least 50mm in diameter. Figure 8 compares categories of tumour size from 1997 to 2012. Figure 8: Breast cancer Size of histologically confirmed tumours 1997-2012 Percentage of cases 50 45 40 35 30 25 20 15 10 5 0 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Year 01-09 mm 10-19 mm 20-49 mm 50+ mm Lymph node involvement Of the 394 primary breast cancer cases (female), lymph nodes were investigated in 326 (83%) of cases. Where nodal status was examined, 203 (62%) cases were classified as lymph node negative, 96 (29%) cases involved 1 to 3 lymph nodes, 18 (6%) cases involved 4 to 6 lymph nodes, and 7 (2%) cases involved 7 or more lymph nodes. Figure 9 compares categories of lymph node involvement from 1997 to 2012. Figure 9: Breast cancer Lymph node involvement 1997-2012 70 Percentage of cases 60 50 40 30 20 10 0 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Year 0 nodes 1-3 nodes 4-6 nodes 7+ nodes a Refer to Indices of Data Quality on page 68. 14 Tasmanian Cancer Registry
Regional Distribution of Cancers The regional distribution of common cancers is shown as the number of cases and the percentage of all cases of each cancer site in each statistical division (Table 1). This information is based on recorded postcode of residence. On the basis of population numbers in each of the statistical divisions, the distribution of cancers would be expected to be 48% in the South, 28% in the North and 23% in the Mersey-Lyell division. Variation around that distribution can be expected due to chance occurrences and differences in the age distribution between the regional populations. Table 1: Regional distribution of cancer incidence for all sites with a minimum of 50 new cases 2012 ICD-10 Site Southern Northern Mersey-Lyell Total a (%) (%) (%) (100%) C18 - C21 Colorectal 214 (48%) 127 (28%) 108 (24%) 449 C61 Prostate 207 (46%) 127 (28%) 112 (25%) 446 C50 Breast 205 (52%) 111 (28%) 81 (20%) 397 C33, C34 Lung 145 (45%) 105 (33%) 72 (22%) 322 C43 Melanoma of skin 125 (48%) 78 (30%) 58 (22%) 261 C81 - C85 All lymphomas 67 (50%) 43 (32%) 25 (19%) 135 C64 Kidney 52 (50%) 31 (30%) 22 (21%) 105 C01-C14,C30-C32 Head and neck 46 (52%) 25 (28%) 18 (20%) 89 C25 Pancreas 41 (47%) 18 (21%) 28 (32%) 87 C67 Bladder 36 (47%) 14 (18%) 26 (34%) 76 C15 Oesophagus 38 (56%) 11 (16%) 19 (28%) 68 C91 - C95 All leukaemia 37 (54%) 18 (26%) 13 (19%) 68 C71 Brain 26 (44%) 19 (32%) 14 (24%) 59 Total new cases 1,239 (48%) 727 (28%) 596 (23%) 2562 Row totals may not add up to 100% due to rounding. a Estimated Residential Population for region (% of Tasmanian population) as of 30 th June, 2012. Tasmanian Cancer Registry 15
Common Cancers by Local Government Area Common cancers (total number of cases (2008-12) are presented for each Local Government Area (LGA) below with the standardised incidence ratio (SIR) and 99% confidence interval (CI) comparing the incidence in a given LGA with the incidence in Tasmania as a whole (see page 62 for details of methods). SIRs greater than 100 are suggestive of a higher than expected incidence, this being statistically significant only when the corresponding lower 99% confidence interval is greater than 100. Overall, there is little variation in the incidence for cancers across Tasmania by local government area. Statistically significant differences in incidence rates were found for the following: males living in the Clarence LGA with above average incidence of prostate cancer, males living in the Central Coast and Derwent Valley with below average incidence of prostate cancer, males living in the Meander Valley LGA with below average incidence of all cancers combined, females living in the Hobart LGA with below average incidence of lung cancer, females living in the Meander Valley with below average incidence of all cancers combined, all persons combined living in the Hobart LGA with below average incidence of lung cancer and persons living in the Meander Valley with lower than expected incidence of all cancers combined. Common Cancers Diagnosed in Males between 2008-2012 Prostate Cancer * Colorectal Cancer Lung Cancer Melanoma All Cancers 99% CI 99% CI 99% CI 99% CI 99% CI Local Government Area SIR L U SIR L U SIR L U SIR L U SIR L U Break O Day (M) 45 94 76 113 24 104 49 158 21 123 68 177 22 120 77 164 180 104 91 117 Brighton (M) 57 98 80 117 30 112 57 168 25 134 78 191 11 86 51 121 216 106 93 119 Burnie (C) 108 101 84 117 50 105 67 144 30 97 59 135 17 80 49 110 337 100 89 110 Central Coast (M) 95 84 69 98 69 110 75 145 44 104 69 140 42 108 75 141 425 98 88 108 Central Highlands (M) 19 99 78 120 4 65 0 134 7 118 50 186 2 92 49 135 50 99 84 114 Circular Head (M) 48 102 82 121 26 132 63 201 16 117 61 173 13 102 61 142 155 104 91 118 Clarence (C) 346 112 99 125 124 94 73 116 89 98 73 123 101 119 92 146 1028 106 98 114 Derwent Valley (M) 39 91 73 109 32 123 62 184 34 168 105 231 14 97 59 136 166 98 86 111 Devonport (C) 148 100 84 115 78 113 79 147 48 104 70 138 46 109 77 142 518 106 96 116 Dorset (M) 50 100 81 120 21 100 44 155 22 131 74 189 9 91 53 130 148 99 86 113 (C) = City (M) = Municipality SIR = smoothed standardised incidence ratio. L = Lower 99% Confidence Interval, U = Upper 99% Confidence Interval. sss grey highlighting indicates a statistically significant difference in the incidence of cancer in the LGA compared to the incidence of cancer for Tasmania as a whole. Confidence intervals are rounded to whole numbers, but 3 decimal places are used to determine significance. Tasmanian Cancer Registry 16 DRAFT ONLY (IN CONFIDENCE)
Prostate Cancer * Colorectal Cancer Lung Cancer Melanoma All Cancers 99% CI 99% CI 99% CI 99% CI 99% CI Local Government Area SIR L U SIR L U SIR L U SIR L U SIR L U Flinders (M) 9 99 77 121 4 128 0 298 4 121 46 196 1 96 51 141 23 100 84 116 George Town (M) 32 94 75 112 22 117 50 184 25 157 92 223 9 95 55 134 148 105 91 119 Glamorgan/Spring Bay (M) 44 100 80 119 14 82 28 135 5 74 29 119 11 102 60 144 125 99 86 113 Glenorchy (C) 234 100 87 114 111 101 76 127 59 83 57 108 59 93 68 119 773 100 92 108 Hobart (C) 266 106 92 119 111 99 75 124 59 82 57 107 63 93 68 118 789 98 90 106 Huon Valley (M) 82 93 77 110 28 75 43 108 28 103 62 144 23 96 61 130 275 96 85 106 Kentish (M) 28 93 74 112 18 110 42 177 12 110 53 166 13 107 64 149 100 95 82 109 King Island (M) 11 98 76 119 7 131 1 260 6 122 50 194 8 114 65 162 47 103 87 119 Kingborough (M) 216 111 96 127 83 101 72 130 35 72 46 99 43 92 64 120 593 102 93 111 Latrobe (M) 61 98 80 116 30 107 56 157 16 94 49 139 17 101 62 139 187 97 85 109 Launceston (C) 337 102 90 114 140 94 74 115 112 108 83 133 97 104 80 128 1107 102 95 109 Meander Valley (M) 90 90 74 106 37 80 49 111 21 74 41 106 22 85 54 116 261 83 73 93 Northern Midlands (M) 76 98 80 115 33 95 53 137 30 120 73 167 19 96 60 132 231 96 85 108 Sorell (M) 72 98 80 116 33 99 54 144 24 108 62 154 25 110 71 148 250 103 91 115 Southern Midlands (M) 30 95 75 114 18 111 41 181 9 99 45 153 4 84 46 122 104 97 83 111 Tasman (M) 18 97 76 117 4 56 0 114 5 100 39 160 2 90 48 132 64 100 85 115 Waratah/Wynyard (M) 74 93 76 110 41 104 62 145 32 114 71 158 23 99 63 134 259 96 84 107 West Coast (M) 23 95 75 114 16 124 42 206 10 113 52 174 6 94 53 135 94 101 86 115 West Tamar (M) 122 95 80 111 63 104 70 138 35 91 57 125 39 105 72 138 410 97 87 107 Tasmanian Cancer Registry 17
Common Cancers Diagnosed in Females between 2008-2012 Breast Cancer Colorectal Cancer Lung Cancer Melanoma All Cancers 99% CI 99% CI 99% CI 99% CI 99% CI Local Government Area SIR L U SIR L U SIR L U SIR L U SIR L U Break O Day (M) 15 83 56 110 11 96 75 118 15 110 72 149 6 93 57 130 86 95 81 109 Brighton (M) 34 91 65 117 16 97 76 118 12 101 64 137 7 85 52 118 131 97 84 110 Burnie (C) 59 93 70 115 63 113 92 134 37 120 84 155 22 97 65 130 301 108 96 120 Central Coast (M) 69 89 68 110 48 98 79 117 24 91 61 120 42 121 86 157 300 96 85 107 Central Highlands (M) 8 98 64 131 4 100 77 123 4 102 62 143 2 97 57 138 28 99 83 115 Circular Head (M) 22 95 66 124 13 99 77 121 6 95 58 131 8 98 60 136 85 97 83 111 Clarence (C) 182 96 80 113 109 96 79 112 66 97 73 122 71 106 79 132 729 98 90 107 Derwent Valley (M) 20 83 57 109 22 102 80 124 8 93 58 129 7 91 55 126 112 97 83 110 Devonport (C) 89 97 75 118 78 109 89 129 36 100 70 130 37 106 74 138 402 104 93 114 Dorset (M) 17 86 59 114 17 100 78 122 12 104 66 141 7 95 58 132 89 95 81 109 Flinders (M) 7 104 68 140 0 98 75 121 1 98 58 138 0 96 55 137 15 100 83 116 George Town (M) 24 101 70 131 12 99 77 121 10 104 66 142 7 98 60 136 90 101 87 116 Glamorgan/Spring Bay (M) 27 108 76 140 15 102 79 124 5 94 58 131 8 103 63 143 85 102 88 117 Glenorchy (C) 180 110 91 128 97 96 80 113 89 128 99 158 47 90 65 115 692 105 96 114 Hobart (C) 198 115 96 134 110 103 86 121 34 75 53 98 60 101 74 127 661 101 92 110 Huon Valley (M) 54 100 75 126 24 96 76 117 15 96 62 129 14 93 59 127 174 96 83 108 Kentish (M) 12 86 58 115 13 101 79 124 3 92 55 128 10 106 66 146 78 101 86 116 King Island (M) 5 97 63 131 2 99 76 122 3 102 61 143 2 99 58 141 19 99 83 115 Kingborough (M) 139 112 91 133 67 99 80 117 32 90 62 117 49 111 80 142 460 102 92 112 Latrobe (M) 33 95 68 122 23 100 79 122 9 91 57 125 20 115 76 154 149 102 88 116 Launceston (C) 214 98 82 113 148 102 86 118 90 108 83 132 75 97 74 121 893 101 93 109 (C) = City (M) = Municipality SIR = smoothed standardised incidence ratio. L = Lower 99% Confidence Interval, U = Upper 99% Confidence Interval. sss grey highlighting indicates a statistically significant difference in the incidence of cancer in the LGA compared to the incidence of cancer for Tasmania as a whole. Confidence intervals are rounded to whole numbers, but 3 decimal places are used to determine significance. Tasmanian Cancer Registry 18 DRAFT ONLY (IN CONFIDENCE)
Breast Cancer Colorectal Cancer Lung Cancer Melanoma All Cancers 99% CI 99% CI 99% CI 99% CI 99% CI Local Government Area SIR L U SIR L U SIR L U SIR L U SIR L U Meander Valley (M) 54 86 64 107 29 91 72 111 20 92 61 123 18 90 59 121 197 85 74 96 Northern Midlands (M) 40 94 68 120 27 100 79 122 13 95 61 129 13 96 61 131 156 97 84 109 Sorell (M) 50 105 78 132 22 98 77 118 10 91 57 124 20 109 71 146 159 98 85 111 Southern Midlands (M) 30 113 80 146 10 99 77 122 8 103 64 142 9 105 65 145 87 105 90 120 Tasman (M) 9 97 64 130 8 102 79 125 3 98 59 137 1 94 54 133 35 99 83 115 Waratah/Wynyard (M) 58 104 78 130 41 106 84 127 18 98 64 131 16 96 62 130 213 102 90 115 West Coast (M) 15 99 67 131 11 102 79 125 6 103 63 142 0 87 50 124 65 104 88 120 West Tamar (M) 87 104 81 127 41 95 76 115 32 104 72 136 23 93 62 124 295 97 86 108 Tasmanian Cancer Registry 19
Common Cancers Diagnosed in All Persons between 2008-2012 All Lymphomas Colorectal Cancer Lung Cancer Melanoma All Cancers 99% CI 99% CI 99% CI 99% CI 99% CI Local Government Area SIR L U SIR L U SIR L U SIR L U SIR L U Break O Day (M) 7 90 53 127 35 99 83 115 36 126 84 168 28 113 74 153 266 101 90 112 Brighton (M) 19 107 68 146 46 101 85 117 37 122 81 162 18 76 47 106 347 103 92 114 Burnie (C) 15 80 50 110 113 108 93 123 67 115 84 146 39 83 57 110 638 104 95 113 Central Coast (M) 38 108 75 141 117 101 87 116 68 97 71 123 84 122 92 152 725 97 89 105 Central Highlands (M) 3 97 54 139 8 99 82 116 11 116 65 167 4 90 48 133 78 100 86 113 Circular Head (M) 9 96 57 135 39 103 86 119 22 106 65 146 21 101 63 139 240 102 91 114 Clarence (C) 98 123 95 151 233 96 84 107 155 97 78 116 172 115 94 136 1757 102 97 108 Derwent Valley (M) 8 88 52 124 54 105 88 121 42 133 91 176 21 90 56 124 278 97 87 108 Devonport (C) 30 89 60 119 156 108 93 122 84 102 77 128 83 111 83 138 920 105 97 113 Dorset (M) 10 96 58 135 38 101 84 117 34 123 81 165 16 89 53 124 237 97 86 108 Flinders (M) 5 108 62 154 4 100 83 117 5 111 57 165 1 92 46 138 38 101 86 115 George Town (M) 9 98 58 138 34 102 85 118 35 139 92 186 16 94 57 132 238 106 94 117 Glamorgan/Spring Bay (M) 6 93 54 132 29 100 84 117 10 81 45 116 19 107 66 147 210 102 91 114 Glenorchy (C) 56 93 67 119 208 98 86 111 148 107 86 129 106 89 69 109 1465 102 95 108 Hobart (C) 72 107 80 135 221 102 89 114 93 75 57 92 123 96 76 116 1450 99 93 105 Huon Valley (M) 14 86 53 119 52 94 79 109 43 100 68 132 37 93 62 123 449 96 87 105 Kentish (M) 9 101 60 141 31 102 86 119 15 98 57 139 23 114 72 156 178 98 86 110 King Island (M) 5 105 60 150 9 101 84 118 9 118 65 172 10 115 66 165 66 103 89 117 Kingborough (M) 48 104 74 134 150 100 87 114 67 78 57 99 92 102 78 126 1053 102 95 110 Latrobe (M) 11 91 55 127 53 101 86 117 25 89 56 122 37 115 78 152 336 100 89 110 Launceston (C) 91 104 79 128 288 99 88 110 202 108 90 127 172 100 82 119 2000 101 95 106 (C) = City (M) = Municipality SIR = smoothed standardised incidence ratio. L = Lower 99% Confidence Interval, U = Upper 99% Confidence Interval. sss grey highlighting indicates a statistically significant difference in the incidence of cancer in the LGA compared to the incidence of cancer for Tasmania as a whole. Confidence intervals are rounded to whole numbers, but 3 decimal places are used to determine significance. Tasmanian Cancer Registry 20 DRAFT ONLY (IN CONFIDENCE)
All Lymphomas Colorectal Cancer Lung Cancer Melanoma All Cancers 99% CI 99% CI 99% CI 99% CI 99% CI Local Government Area SIR L U SIR L U SIR L U SIR L U SIR L U Meander Valley (M) 17 82 52 112 66 91 78 105 41 79 54 104 40 82 56 108 458 81 73 89 Northern Midlands (M) 18 99 63 136 60 100 85 115 43 109 74 143 32 94 62 126 387 96 87 106 Sorell (M) 18 100 63 137 55 99 84 115 34 98 65 131 45 116 81 152 409 102 92 112 Southern Midlands (M) 6 94 54 133 28 101 85 118 17 105 62 148 13 92 54 130 191 102 90 114 Tasman (M) 6 103 60 147 12 100 83 116 8 100 54 146 3 84 44 125 99 101 88 114 Waratah/Wynyard (M) 16 90 56 124 82 104 88 119 50 108 75 140 39 97 66 128 472 99 90 108 West Coast (M) 6 98 57 139 27 103 86 120 16 113 67 160 6 82 45 120 159 105 92 117 West Tamar (M) 30 97 65 129 104 99 85 113 67 99 72 126 62 99 72 126 705 97 89 105 Tasmanian Cancer Registry 21
22 Tasmanian Cancer Registry
Cancer incidence and mortality table 2012 - Numbers of new cases and deaths - Age-specific incidence and mortality rates per 100,000 - Crude incidence and mortality rates per 100,000 (Crude s) - Cumulative incidence and mortality rates (Cumul s) - Age standardised incidence and mortality rates using the Australian Standard Population (2001), the World Standard Population (1960) and the World Standard Population (2000) Tasmanian Cancer Registry 23
Cancer Incidence and Mortality in Tasmania 2012 by age, sex and site C00. Lip 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ Total Crude Cumul AS s W W AUS M 0 0 0 0 0 3 1 1 1 2 6 3 2 2 2 5 2 1 31 F 0 0 0 0 0 0 0 1 0 2 2 1 3 1 0 3 1 1 15 P 0 0 0 0 0 3 1 2 1 4 8 4 5 3 2 8 3 2 46 M 0.0 0.0 0.0 0.0 0.0 19.7 7.0 6.7 5.8 11.7 32.0 17.1 12.0 14.1 19.3 70.6 40.0 26.4 12.1 0.7 8.1 9.1 11.3 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 11.3 10.5 5.6 18.4 7.2 0.0 37.2 15.6 14.6 5.8 0.3 3.3 3.7 4.8 P 0.0 0.0 0.0 0.0 0.0 9.9 3.5 6.6 2.8 11.5 21.1 11.3 15.2 10.7 9.7 52.8 26.3 18.8 9.0 0.5 5.6 6.3 8.0 M 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 2 F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 2 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 9.6 0.0 0.0 0.0 0.8 0.1 0.4 0.4 0.6 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 4.8 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.3 C01, C02. Tongue M 0 0 0 0 0 0 0 0 0 0 0 2 1 5 1 1 1 0 11 F 0 0 0 0 0 0 0 0 0 0 0 1 4 2 1 1 0 0 9 P 0 0 0 0 0 0 0 0 0 0 0 3 5 7 2 2 1 0 20 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 6.0 35.4 9.6 14.1 20.0 0.0 4.3 0.3 2.2 2.4 3.1 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 24.5 14.4 9.7 12.4 0.0 0.0 3.5 0.3 2.0 2.0 2.5 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 15.2 25.0 9.7 13.2 8.8 0.0 3.9 0.3 2.1 2.2 2.8 M 0 0 0 0 0 0 0 0 0 0 1 0 1 2 0 0 2 0 6 F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 3 P 0 0 0 0 0 0 0 0 0 0 1 0 1 2 3 0 2 0 9 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 6.0 14.1 0.0 0.0 40.0 0.0 2.3 0.1 1.1 1.3 1.8 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.2 0.0 0.0 0.0 1.2 0.1 0.6 0.6 1.0 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 3.0 7.1 14.5 0.0 17.5 0.0 1.8 0.1 0.8 0.9 1.3 Tasmanian Cancer Registry 24
Cancer Incidence and Mortality in Tasmania 2012 by age, sex and site C03. Gum 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ Total Crude Cumul AS s W W AUS M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 F 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 P 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.4 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.2 M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C04. Floor of mouth M 0 0 0 0 0 0 0 0 0 0 0 4 1 0 0 0 0 0 5 F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 P 0 0 0 0 0 0 0 0 0 0 0 4 1 0 0 0 0 1 6 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 6.0 0.0 0.0 0.0 0.0 0.0 2.0 0.1 1.2 1.3 1.4 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.4 0.0 0.1 0.1 0.2 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 3.0 0.0 0.0 0.0 0.0 9.4 1.2 0.1 0.6 0.7 0.8 M 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.2 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 Tasmanian Cancer Registry 25
Cancer Incidence and Mortality in Tasmania 2012 by age, sex and site C05, C06. Other mouth 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ Total Crude Cumul AS s W W AUS M 0 0 0 0 0 0 0 0 0 0 2 1 0 0 0 0 0 2 5 F 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1 3 P 0 0 0 0 0 0 0 0 0 0 2 2 0 0 1 0 0 3 8 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 5.7 0.0 0.0 0.0 0.0 0.0 52.9 2.0 0.1 1.0 1.2 1.7 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 9.7 0.0 0.0 14.6 1.2 0.1 0.5 0.6 0.8 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.7 0.0 0.0 4.8 0.0 0.0 28.3 1.6 0.1 0.7 0.8 1.2 M 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 F 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 P 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 2 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.3 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.3 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.6 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.3 C01 - C06. Oral Cavity M 0 0 0 0 0 0 0 0 0 0 2 7 2 5 1 1 1 2 21 F 0 0 0 0 0 0 0 0 0 0 1 2 4 2 2 1 0 2 14 P 0 0 0 0 0 0 0 0 0 0 3 9 6 7 3 2 1 4 35 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 40.0 12.0 35.4 9.6 14.1 20.0 52.9 8.2 0.5 4.4 4.8 6.3 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 11.2 24.5 14.4 19.4 12.4 0.0 29.3 5.4 0.4 2.8 2.9 3.8 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 25.5 18.2 25.0 14.5 13.2 8.8 37.7 6.8 0.5 3.5 3.8 5.0 M 0 0 0 0 0 0 0 0 0 0 1 0 2 3 0 0 2 0 8 F 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 0 0 4 P 0 0 0 0 0 0 0 0 0 0 1 0 2 4 3 0 2 0 12 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 12.0 21.2 0.0 0.0 40.0 0.0 3.1 0.2 1.6 1.7 2.3 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 29.2 0.0 0.0 0.0 1.6 0.2 0.8 0.9 1.2 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 6.1 14.3 14.5 0.0 17.5 0.0 2.3 0.2 1.2 1.3 1.7 Tasmanian Cancer Registry 26
Cancer Incidence and Mortality in Tasmania 2012 by age, sex and site C07, C08. Salivary glands 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ Total Crude Cumul AS s W W AUS M 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 1 1 4 F 0 0 0 0 0 0 0 0 0 0 0 2 0 0 1 1 0 0 4 P 0 0 0 0 0 0 0 0 0 1 0 2 0 1 1 1 1 1 8 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 7.1 0.0 0.0 20.0 26.4 1.6 0.1 0.8 0.9 1.4 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 9.7 12.4 0.0 0.0 1.6 0.1 0.8 0.9 1.2 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 5.7 0.0 3.6 4.8 6.6 8.8 9.4 1.6 0.1 0.8 0.9 1.2 M 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 F 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 P 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 2 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.2 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.3 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.3 C09, C10. Oropharynx M 0 0 0 0 0 0 0 0 0 1 3 1 2 1 1 0 0 0 9 F 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 3 P 0 0 0 0 0 0 0 0 0 1 3 1 3 2 1 1 0 0 12 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 16.0 5.7 12.0 7.1 9.6 0.0 0.0 0.0 3.5 0.3 2.3 2.3 2.9 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 7.2 0.0 12.4 0.0 0.0 1.2 0.1 0.6 0.6 0.8 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.9 2.8 9.1 7.1 4.8 6.6 0.0 0.0 2.3 0.2 1.4 1.5 1.9 M 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 1 4 F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 1 4 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.7 0.0 0.0 0.0 14.1 0.0 26.4 1.6 0.1 0.8 0.9 1.4 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.8 0.0 0.0 0.0 6.6 0.0 9.4 0.8 0.0 0.4 0.4 0.6 Tasmanian Cancer Registry 27
Cancer Incidence and Mortality in Tasmania 2012 by age, sex and site C11. Nasopharynx 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ Total Crude Cumul AS s W W AUS M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 M 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 2 F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 2 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.8 0.1 0.5 0.6 0.7 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.4 C12, C13. Hypopharynx M 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 4 F 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 P 0 0 0 0 0 0 0 0 0 0 0 0 1 3 1 0 0 0 5 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 14.1 9.6 0.0 0.0 0.0 1.6 0.1 0.9 0.9 1.1 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.3 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 10.7 4.8 0.0 0.0 0.0 1.0 0.1 0.5 0.5 0.7 M 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.2 0.3 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 Tasmanian Cancer Registry 28
Cancer Incidence and Mortality in Tasmania 2012 by age, sex and site C09 - C13. Pharynx 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ Total Crude Cumul AS s W W AUS M 0 0 0 0 0 0 0 0 0 1 3 1 3 3 2 0 0 0 13 F 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 1 0 0 4 P 0 0 0 0 0 0 0 0 0 1 3 1 4 5 2 1 0 0 17 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 16.0 5.7 18.0 21.2 19.3 0.0 0.0 0.0 5.1 0.4 3.1 3.2 3.9 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 14.4 0.0 12.4 0.0 0.0 1.6 0.1 0.8 0.8 1.1 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.9 2.8 12.1 17.9 9.7 6.6 0.0 0.0 3.3 0.3 2.0 2.0 2.5 M 0 0 0 0 0 0 0 0 0 1 1 1 1 0 1 1 0 1 7 F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P 0 0 0 0 0 0 0 0 0 1 1 1 1 0 1 1 0 1 7 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 5.3 5.7 6.0 0.0 9.6 14.1 0.0 26.4 2.7 0.2 1.6 1.7 2.4 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 2.6 2.8 3.0 0.0 4.8 6.6 0.0 9.4 1.4 0.1 0.7 0.8 1.1 C14. Other oral M 0 0 0 0 0 0 0 0 0 0 1 1 1 0 1 0 0 0 4 F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 P 0 0 0 0 0 0 0 0 0 0 1 1 1 0 1 0 0 0 4 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.7 6.0 0.0 9.6 0.0 0.0 0.0 1.6 0.1 0.9 1.0 1.2 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.8 3.0 0.0 4.8 0.0 0.0 0.0 0.8 0.1 0.5 0.5 0.6 M 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 2 F 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 P 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 3 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 9.6 0.0 0.0 0.0 0.8 0.1 0.4 0.4 0.6 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.3 0.4 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 3.6 4.8 0.0 0.0 0.0 0.6 0.1 0.3 0.4 0.5 Tasmanian Cancer Registry 29
Cancer Incidence and Mortality in Tasmania 2012 by age, sex and site 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ Total Crude C01-C14,C30-C32. Head and neck Cumul AS s W W AUS M 0 0 0 0 0 0 0 0 1 3 8 11 12 11 7 4 4 4 65 F 0 0 0 0 0 0 0 0 1 0 1 5 5 4 3 3 0 2 24 P 0 0 0 0 0 0 0 0 2 3 9 16 17 15 10 7 4 6 89 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 17.6 42.6 62.9 72.1 77.8 67.5 56.5 80.0 105.7 25.4 1.7 14.1 15.3 20.1 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 5.2 28.0 30.6 28.8 29.2 37.2 0.0 29.3 9.3 0.6 4.9 5.3 6.9 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 8.7 23.8 45.3 51.6 53.6 48.4 46.2 35.0 56.5 17.4 1.2 9.4 10.2 13.2 M 0 0 0 0 0 0 0 0 0 3 2 3 6 7 2 3 4 3 33 F 0 0 0 0 0 0 0 0 0 0 1 0 0 2 3 1 0 0 7 P 0 0 0 0 0 0 0 0 0 3 3 3 6 9 5 4 4 3 40 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 10.7 17.1 36.0 49.5 19.3 42.4 80.0 79.3 12.9 0.8 6.8 7.5 10.3 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 14.4 29.2 12.4 0.0 0.0 2.7 0.2 1.4 1.5 2.1 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 7.9 8.5 18.2 32.1 24.2 26.4 35.0 28.3 7.8 0.5 4.0 4.4 6.0 C15. Oesophagus M 0 0 0 0 0 0 0 1 0 2 1 5 12 5 7 6 4 5 48 F 0 0 0 0 0 0 0 0 1 0 1 0 0 1 1 4 3 9 20 P 0 0 0 0 0 0 0 1 1 2 2 5 12 6 8 10 7 14 68 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 11.7 5.3 28.6 72.1 35.4 67.5 84.7 80.0 132.2 18.8 1.1 9.7 10.8 15.1 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 5.2 0.0 0.0 7.2 9.7 49.5 46.7 131.7 7.8 0.1 2.4 3.1 5.3 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 2.8 5.8 5.3 14.2 36.4 21.4 38.7 66.0 61.3 131.9 13.3 0.6 6.0 6.9 10.1 M 0 0 0 0 0 0 0 0 1 0 1 5 6 2 6 3 1 1 26 F 0 0 0 0 0 0 0 0 1 0 1 0 0 1 2 3 5 6 19 P 0 0 0 0 0 0 0 0 2 0 2 5 6 3 8 6 6 7 45 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 5.3 28.6 36.0 14.1 57.9 42.4 20.0 26.4 10.2 0.7 5.4 6.0 8.0 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 5.2 0.0 0.0 7.2 19.4 37.2 77.9 87.8 7.4 0.2 2.4 3.1 5.2 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 5.3 14.2 18.2 10.7 38.7 39.6 52.5 65.9 8.8 0.5 4.0 4.6 6.8 Tasmanian Cancer Registry 30
Cancer Incidence and Mortality in Tasmania 2012 by age, sex and site C16. Stomach 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+ Total Crude Cumul AS s W W AUS M 0 0 0 0 0 0 0 1 0 0 2 2 5 3 3 5 5 4 30 F 0 0 0 0 1 0 0 0 0 3 1 2 1 2 1 2 2 3 18 P 0 0 0 0 1 0 0 1 0 3 3 4 6 5 4 7 7 7 48 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 10.7 11.4 30.0 21.2 28.9 70.6 100.0 105.7 11.7 0.5 5.5 6.6 9.8 F 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 17.0 5.2 11.2 6.1 14.4 9.7 24.8 31.1 43.9 7.0 0.4 3.7 4.2 5.4 P 0.0 0.0 0.0 0.0 3.1 0.0 0.0 3.3 0.0 8.7 7.9 11.3 18.2 17.9 19.4 46.2 61.3 65.9 9.4 0.4 4.6 5.3 7.4 M 0 0 0 0 0 0 0 0 0 0 2 1 1 5 8 6 4 4 31 F 0 0 0 0 1 0 0 0 0 0 1 2 2 2 2 2 2 3 17 P 0 0 0 0 1 0 0 0 0 0 3 3 3 7 10 8 6 7 48 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 5.7 6.0 35.4 77.2 84.7 80.0 105.7 12.1 0.7 5.4 6.5 10.1 F 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 5.2 11.2 12.3 14.4 19.4 24.8 31.1 43.9 6.6 0.3 3.2 3.6 4.8 P 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 7.9 8.5 9.1 25.0 48.4 52.8 52.5 65.9 9.4 0.5 4.2 4.9 7.2 C17. Small intestine M 0 0 0 0 0 0 0 0 0 0 1 0 1 0 1 0 0 0 3 F 0 0 0 0 0 0 0 1 0 1 0 1 1 1 1 1 1 0 8 P 0 0 0 0 0 0 0 1 0 1 1 1 2 1 2 1 1 0 11 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 6.0 0.0 9.6 0.0 0.0 0.0 1.2 0.1 0.7 0.7 0.9 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 5.7 0.0 5.6 6.1 7.2 9.7 12.4 15.6 0.0 3.1 0.2 1.8 2.0 2.6 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 2.9 2.6 2.8 6.1 3.6 9.7 6.6 8.8 0.0 2.1 0.2 1.3 1.4 1.8 M 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 F 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 2 P 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 1 3 M 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.4 0.4 F 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.6 0.8 0.0 0.4 0.5 0.6 P 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.6 0.0 0.4 0.4 0.5 Tasmanian Cancer Registry 31